Literature DB >> 7776704

Differential cell count and lymphocyte subsets in bronchoalveolar lavage during pneumonia with and without peripheral neutropenia.

M von Eiff1, O Schlingheider, F Schulze, M Zühlsdorf, J van de Loo.   

Abstract

One hundred immunocompromised HIV negative patients with microbiologically positive pneumonia underwent bronchoalveolar lavage (BAL) studies. Thirty cases showed peripheral neutropenia (< 1000 neutrophils/microL), 70 did not. The total cell number in BAL, the differential cell counts, and the lymphocyte subsets (CD4, CD8, CD19, CD57) were measured. Patients with pneumonia and normal or elevated peripheral neutrophils had a significantly increased total number of cells in BAL compared to patients with peripheral neutropenia (3.2 +/- 2 vs 1.3 +/- 0.6 x 10(5) cells/ml2 lavage fluid, p < 0.01). Ninety percent of the BAL differential cell counts obtained in patients exceeding 1000 neutrophils/microL showed a lymphocytic and/or neutrophilic alveolitis, whereas only 54% of patients with peripheral neutropenia displayed abnormal counts (p < 0.01). Yet the typical pattern of neutrophilic alveolitis was found more often for peripheral neutrophil counts over 1000/microL with high significance (p < 0.0001). Abnormal BAL cell patterns for neutropenic patients uniformly showed a lymphocytic alveolitis, only 10% additionally conformed with the pattern of neutrophilic alveolitis. Patients with pneumonia with and without peripheral neutropenia had similar findings in BAL lymphocyte subsets and exhibited a reduced CD4/CD8 ratio compared to controls (p < 0.05). The high susceptibility of severe neutropenic patients to pulmonary, especially fungal infections may be explained by the local lack of neutrophils.

Entities:  

Mesh:

Year:  1995        PMID: 7776704     DOI: 10.1007/bf00167598

Source DB:  PubMed          Journal:  Lung        ISSN: 0341-2040            Impact factor:   2.584


  22 in total

1.  Pulmonary infiltrates in immunocompromised patients. Diagnostic value of telescoping plugged catheter and bronchoalveolar lavage.

Authors:  A Xaubet; A Torres; F Marco; J Puig-De la Bellacasa; R Faus; A Agusti-Vidal
Journal:  Chest       Date:  1989-01       Impact factor: 9.410

Review 2.  Management of fever in patients with cancer and treatment-induced neutropenia.

Authors:  P A Pizzo
Journal:  N Engl J Med       Date:  1993-05-06       Impact factor: 91.245

3.  Prolonged granulocytopenia: the major risk factor for invasive pulmonary aspergillosis in patients with acute leukemia.

Authors:  S L Gerson; G H Talbot; S Hurwitz; B L Strom; E J Lusk; P A Cassileth
Journal:  Ann Intern Med       Date:  1984-03       Impact factor: 25.391

4.  Mechanisms of resistance of Aspergillus fumigatus Conidia to killing by neutrophils in vitro.

Authors:  S M Levitz; R D Diamond
Journal:  J Infect Dis       Date:  1985-07       Impact factor: 5.226

5.  [Pneumonia in immunocompromised patients: the value of non-biopsy bronchoscopic examination procedures in the diagnosis of pathogens].

Authors:  M von Eiff; R Steimann; N Roos; N van Husen; P Walger; P Baumgart; W Fegeler; E Junge; H Baumeister; B Wilms
Journal:  Klin Wochenschr       Date:  1990-04-02

6.  Nosocomial pneumonia in adult patients undergoing bone marrow transplantation: a 9-year study.

Authors:  C S Pannuti; R D Gingrich; M A Pfaller; R P Wenzel
Journal:  J Clin Oncol       Date:  1991-01       Impact factor: 44.544

7.  Fungal infection in chronic granulomatous disease. The importance of the phagocyte in defense against fungi.

Authors:  M S Cohen; R E Isturiz; H L Malech; R K Root; C M Wilfert; L Gutman; R H Buckley
Journal:  Am J Med       Date:  1981-07       Impact factor: 4.965

8.  Multivariate analysis of factors associated with invasive fungal disease during remission induction therapy for acute myelogenous leukemia.

Authors:  R S Schwartz; F R Mackintosh; S L Schrier; P L Greenberg
Journal:  Cancer       Date:  1984-02-01       Impact factor: 6.860

9.  Bronchiolitis obliterans organizing pneumonia (BOOP): the cytological and immunocytological profile of bronchoalveolar lavage.

Authors:  U Costabel; H Teschler; J Guzman
Journal:  Eur Respir J       Date:  1992-07       Impact factor: 16.671

10.  Lymphocyte and lymphocyte subset numbers in blood and in bronchoalveolar lavage and pleural fluid in various forms of human pulmonary tuberculosis at presentation and during recovery.

Authors:  G M Ainslie; J A Solomon; E D Bateman
Journal:  Thorax       Date:  1992-07       Impact factor: 9.139

View more
  2 in total

Review 1.  [Lung involvement in hematologic systemic diseases].

Authors:  S-S Stecher; S Lippl; H J Stemmler; J Schreiber
Journal:  Internist (Berl)       Date:  2018-09       Impact factor: 0.743

2.  The anti-Pseudomonas aeruginosa antibody Panobacumab is efficacious on acute pneumonia in neutropenic mice and has additive effects with meropenem.

Authors:  Thomas Secher; Stefanie Fas; Louis Fauconnier; Marieke Mathieu; Oliver Rutschi; Bernhard Ryffel; Michael Rudolf
Journal:  PLoS One       Date:  2013-09-02       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.